Indeed, we observed that some tumor cell lines recognized by the CD8+ T-cell clone were weakly stained with the SM-3 antibody and another mAb specific for hypoglycosylated MUC1, VU-3-C6. This evidence concerns the gene CD8A and neoplasm.